MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine

    N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

    Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine. Background: Migraine prophylactic treatments are usually taken for short…
  • 2025 International Congress

    Temporal disease patterns prior to Progressive Supranuclear Palsy diagnosis

    M. Fu, T. Chang (Los Angeles, USA)

    Objective: To identify Progressive Supranuclear Palsy (PSP) disease trajectories, defined as the pattern of diagnoses over time, prior to PSP diagnosis in electronic health records.…
  • 2025 International Congress

    Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

    C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)

    Objective: To increase our understanding of the pathogenesis of atypical parkinsonian disorders though genetics, and to build a cohort of individuals for future research. Background:…
  • 2025 International Congress

    A rapidly progressive multiple system atrophy-cerebellar variant model presentingα-synuclein oligomer spreading and phosphorylated α-synuclein aggregate formation accompanied with glial inflammation

    D. Matsuse, H. Yamaguchi, Y. Nishimura, H. Sekiya, K. Masaki, T. Tanaka, T. Saiga, M. Harada, K. Kira, D. Dickson, K. Fujishima, E. Matsuo, K. Tanaka, R. Yamasaki, N. Isobe, J. Kira (Fukuoka, Japan)

    Objective: We aimed to develop a rapidly progressive mouse model that recapitulates MSA-C pathology. Background: Multiple system atrophy (MSA) is a severe α-synucleinopathy driven by…
  • 2025 International Congress

    Multimodal imaging Integrating 18F-APN-1607 and 18F-FP-DTBZ PET in Progressive Supranuclear Palsy

    C. Dong, J. Ma, S. Liu (Beijing, China)

    Objective: To identify the regions with sensitive tau deposition for differentiating progressive supranuclear palsy (PSP) from healthy controls. Additionally, to explore the combination of ​18F-APN-1607…
  • 2025 International Congress

    Expanding the Spectrum of Alzheimer’s Disease Clinical Presentations: Progressive Dysarthria with Monomelic Tremor

    O. Carranza-Renteria, G. Gliebus (Boca Raton, USA)

    Objective: To present an unusual clinical presentation of an atypical Corticobasilar syndrome secondary to Alzheimer's disease. Background: Corticobasilar syndrome (CBS) typically presents with motor symptoms…
  • 2025 International Congress

    Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy

    F. Nery, T. Nevmyrych, J. Murphy, S. Wu, Y. Zabar, A. Gafson, S. Bullain, J. O’Gorman (Cambridge, USA)

    Objective: To compare the properties of PSPRS-28, mPSPRS-15, and the rPSPRS-10 and assess their utility as a primary endpoint in PSP trials. Background: Progressive supranuclear…
  • 2025 International Congress

    Determination of the Minimal Clinically Important Difference in the Yale Global Tic Severity Scale Total Tic Score in a Pediatric Population With Tourette Syndrome Receiving Pharmacotherapy

    J. Mcguire, G. Karkanias, R. Bittman, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Baltimore, USA)

    Objective: The aim was to determine the minimal clinically important difference (MCID) on the Yale Global Tic Severity Scale (YGTSS), using the Clinical Global Impression…
  • 2025 International Congress

    The Efficacy of Neuromodulation for Motor Recovery in Children with Hemiparesis Due to Perinatal Stroke: A Systematic Review and Meta-Analysis.

    I. Andrade, A. de Almeida (Vitória da Conquista, Brazil)

    Objective: To assess the effectiveness of neurostimulation in enhancing motor function in children with perinatal stroke and hemiparetic cerebral palsy. Background: Neuromodulation techniques, including repetitive…
  • 2025 International Congress

    Spinocerebellar Ataxia Recessive Type 7 (SCAR7) in a Consanguineous Family: A Case Report

    T. Ozum, O. Akcin, C. Durmaz, G. Yalcin Cakmakli, B. Elibol (Ankara, Turkey)

    Objective: Spinocerebellar ataxia autosomal recessive type 7 (SCAR7) is a rare disorder caused by biallelic pathogenic variants in TPP1. It usually manifests in childhood or…
  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley